Evolution of the human MUC1 oncoprotein.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Oncology

• Publication date

  2007-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.31.3.671PMID 17671696
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mucin 1 Oncoprotein Blocks Hypoxia-inducible Factor 1α Activation in a Survival Response to Hypoxia*

  2007cited by this paper
• An inventory of mucin genes in the chicken genome shows that the mucin domain of Muc13 is encoded by multiple exons and that ovomucin is part of a locus of related gel-forming mucins

  2006cited by this paper
• Immunohistochemical Analysis of MUC5B Apomucin Expression in Breast Cancer and Non-malignant Breast Tissues

  2006cited by this paper
• MUC1 oncoprotein blocks nuclear targeting of c‐Abl in the apoptotic response to DNA damage

  2006cited by this paper
• MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90

  2006cited by this paper
• Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin

  2006cited by this paper
• Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16.

  2006cited by this paper
• MUC1 oncoprotein stabilizes and activates estrogen receptor alpha.

  2006cited by this paper
• Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.

  2005cited by this paper
• MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin.

  2005cited by this paper
• The MUC1 SEA Module Is a Self-cleaving Domain*

  2005cited by this paper
• Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents.

  2004cited by this paper
• Interaction of human MUC1 and beta-catenin is regulated by Lck and ZAP-70 in activated Jurkat T cells.

  2004cited by this paper
• MUC1 Oncoprotein Activates the FOXO3a Transcription Factor in a Survival Response to Oxidative Stress*

  2004cited by this paper
• MUC1 Cytoplasmic Domain Coactivates Wnt Target Gene Transcription and Confers Transformation

  2003cited by this paper
• Human MUC1 Carcinoma Antigen Regulates Intracellular Oxidant Levels and the Apoptotic Response to Oxidative Stress*

  2003cited by this paper
• Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.

  2003cited by this paper
• Human DF3/MUC1 carcinoma-associated protein functions as an oncogene

  2003cited by this paper
• DF3/MUC1 Signaling In Multiple Myeloma Cells Is Regulated by Interleukin-7

  2003cited by this paper
• The MUC family: an obituary.

  2002cited by this paper
• Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling.

  2002cited by this paper
• Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

  2001cited by this paper
• Aberrant expression of human mucin gene MUC5B in gastric carcinoma and cancer cells. Identification and regulation of a distal promoter.

  2001cited by this paper
• The c-Src Tyrosine Kinase Regulates Signaling of the Human DF3/MUC1 Carcinoma-associated Antigen with GSK3β and β-Catenin*

  2001cited by this paper
• Identification of MUC1 proteolytic cleavage sites in vivo.

  2001cited by this paper
• Proteinuria and Perinatal Lethality in Mice Lacking NEPH1, a Novel Protein with Homology to NEPHRIN

  2001cited by this paper
• Evolution of the large secreted gel-forming mucins.

  2000cited by this paper
• Human KRML (MAFB): cDNA cloning, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias.

  1999cited by this paper
• Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin.

  1998cited by this paper
• Structure and organization of the RBMY genes on the human Y chromosome: transposition and amplification of an ancestral autosomal hnRNPG gene.

  1998cited by this paper
• SMART, a simple modular architecture research tool: identification of signaling domains.

  1998cited by this paper
• Evolutionary History of the 11p15 Human Mucin Gene Family

  1998cited by this paper
• Interaction of the DF3/MUC1 Breast Carcinoma-associated Antigen and β-Catenin in Cell Adhesion*

  1997cited by this paper
• Human Mucin Gene MUC5B, the 10.7-kb Large Central Exon Encodes Various Alternate Subdomains Resulting in a Super-repeat

  1997cited by this paper
• TreeView: an application to display phylogenetic trees on personal computers

  1996cited by this paper
• Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae

  1996cited by this paper
• Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes.

  1996cited by this paper
• The SEA module: A new extracellular domain associated with O‐glycosylation

  1995cited by this paper
• Role of IRS-2 in insulin and cytokine signalling

  1995cited by this paper
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

  1994cited by this paper
• Cell-associated episialin is a complex containing two proteins derived from a common precursor.

  1992cited by this paper
• Report on the first international workshop on carcinoma‐associated mucins

  1991cited by this paper
• Basic local alignment search tool.

  1990cited by this paper
• Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas.

  1989cited by this paper
• A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.

  1988cited by this paper
• Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen.

  1988cited by this paper
• Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

  1984cited by this paper

• Evolution of the MUC1 gene in eutherian mammals as an adaptation responsible for the increasing incidence of cancer in humans.

  2026cites this paper
• Research progress of MUC1 in genitourinary cancers

  2024cites this paper
• MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression

  2023cites this paper
• Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer

  2023cites this paper
• Influence of glycoprotein MUC1 on trafficking of the Ca2+-selective ion channels, TRPV5 and TRPV6, and on in vivo calcium homeostasis

  2023cites this paper
• Influence of MUC1 on trafficking of TRPV5 and TRPV6 and in vivo Ca2+ homeostasis

  2022cites this paper
• Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cells

  2022cites this paper
• Emergence of MUC1 in Mammals for Adaptation of Barrier Epithelia

  2022influential citation
• Characterization of tumor-associated MUC1 and its glycans expressed in mucoepidermoid carcinoma

  2021cites this paper
• EGF-containing Membrane-bound Mucins: a hidden ErbB2 targeting pathway?

  2020cites this paper
• Muc1-c in chronic inflammation and carcinogenesis;emergence as a target for cancer treatment.

  2020cites this paper
• Isolating the role of corticosterone in the hypothalamic-pituitary-gonadal genomic stress response

  2020cites this paper
• MiR-145: a potential biomarker of cancer migration and invasion.

  2019cites this paper
• NMR and molecular recognition of compounds related to the immune system

  2019cites this paper
• Polyethyleneimine-polyethylene glycol copolymer targeted by anti-HER2 nanobody for specific delivery of transcriptionally targeted tBid containing construct

  2019cites this paper
• RESEARCH ARTICLE A CRITIQUE ON CANCER VACCINE.

  2018cites this paper
• MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells

  2018cites this paper
• Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets.

  2018cites this paper
• MUC1-C Oncoprotein Integrates a Program of EMT, Epigenetic Reprogramming and Immune Evasion in Human Carcinomas.

  2017cites this paper
• 20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancer.

  2017cites this paper
• 20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancer

  2017cites this paper
• Biocompatible ELR-Based Polyplexes Coated with MUC1 Specific Aptamers and Targeted for Breast Cancer Gene Therapy.

  2016cites this paper
• MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway

  2016cites this paper
• MUC1 as a Potential Target in Anticancer Therapies

  2015cites this paper
• Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1

  2015cites this paper
• Regulation by IL-10 of innate immune responses to MUC1 as a self-antigen in MUC1 transgenic mice

  2014cites this paper
• TARGETING THE MUC 1-C ONCOPROTEIN DOWNREGULATES HER 2 ACTIVATION AND ABROGATES TRASTUZUMAB RESISTANCE IN BREAST CANCER CELLS

  2014cites this paper
• TARGETING THE MUC1-C ONCOPROTEIN DOWNREGULATES HER2 ACTIVATION AND ABROGATES TRASTUZUMAB RESISTANCE IN BREAST CANCER CELLS

  2013cites this paper
• Novel therapy based on camelid nanobodies.

  2013cites this paper
• Anticancer Property of Bromelain With Therapeutic Potential in Malignant Peritoneal Mesothelioma

  2013cites this paper
• Membrane-bound mucin modular domains: from structure to function.

  2013cites this paper
• ORAL DELIVERY OF PEPTIDE DRUGS FOR MITIGATION OF CROHN'S DISEASE

  2012cites this paper
• MUC1-C Oncoprotein Induces TCF7L2 Transcription Factor Activation and Promotes Cyclin D1 Expression in Human Breast Cancer Cells*

  2012cites this paper
• Potential mucolytic agents for mucinous ascites from pseudomyxoma peritonei

  2012cites this paper
• Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway

  2012cites this paper
• Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells.

  2011cites this paper
• A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

  2011cites this paper
• miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death.

  2010cites this paper
• MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer.

  2009cites this paper
• Where Do We Place PankoMab in the Reagents Used to Study the MUC1 Superfamily?

  2009cites this paper
• Mucins in cancer: function, prognosis and therapy

  2009cites this paper
• Mucus layer properties and dynamics in reef corals

  2009influential citation
• HSP70 and mucin 5B: novel protein targets of N,N′‐dinitrosopiperazine‐induced nasopharyngeal tumorigenesis

  2009cites this paper